期刊文献+

肥胖合并或不合并2型糖尿病患者血清单核细胞趋化蛋白-1浓度与胰岛素敏感性的关系 被引量:2

Serum MCP-1 Concentration in Relation to Insulin Sensitivity in the Glucose Clamp Study in Obese Patients and Type 2 Diabetic Patients with Obesity
暂未订购
导出
摘要 目的:比较肥胖合并或不合并2型糖尿病患者血清单核细胞趋化蛋白-1(MCP-1)浓度与葡萄糖钳夹试验中胰岛素敏感性的关系。方法:分别对20例正常糖耐量者和40例肥胖患者(其中合并2型糖尿病者20例,无糖尿病者20例)进行高胰岛素-葡萄糖钳夹试验,以钳夹稳态期胰岛素介导的葡萄糖利用率(Rd)来判定周围组织胰岛素敏感性。同时用酶联免疫吸附法(ELISA)测定血清MCP-1水平,并测定其他临床指标,分析各指标之间的相关性及与胰岛素敏感性的关系。结果:与正常体质量组相比,肥胖患者外周血MCP-1水平明显升高(P<0.01),Rd值明显降低(P<0.01),合并糖尿病者其变化明显大于无糖尿病者。两指标呈明显负相关(r=-0.440,P=0.004)。MCP-1是胰岛素敏感性的独立影响因素。结论:外周血MCP-1是胰岛素抵抗的独立影响因素,又与腰围紧密联系,促进胰岛素抵抗的发展。预防和控制腹型肥胖将有助于降低MCP-1水平,改善胰岛素抵抗。 Objective:To evaluate the serum MCP-1 in relation to insulin sensitivity in the glucose clamp study in obese patients and type 2 diabetic patients with obesity. Methods:Hyperinsulinemic euglysemic clamp was performed in 20 normal weight and 40 cases of obesity (including 20 type 2 diabetic patients with obesity and 20 obesity without diabetes). The rate of insulin-mediated glucose disposal(Rd)during the steady state of glucose clamp was used to assess the peripheral tissue insulin sensitivity. Before the clamp study ,Serum MCP-1 was determined by Enzyme Linked ImmunoSorbent Assay(ELISA) and other clinical parameters were determined to analyse the relationship between them.Results:In obese patients ,serum MCP-1 were higher remarkedly than those in normal weight and Rd were lower. MCP-1 in obesity with type 2 diabetes were higher than that in obesity without diabetes (P0.01) and Rd were lower(P0.05). They were negative correlation significantly (r=-0.440,P=0.004). MCP-1 was the independent contributing factor for Rd. Conclusions:The serum MCP-1 level is the independent contributing factor for insulin sensitivity and it contributes to the development of insulin resistance with waist. Preventing abdominal obesity will contribute to decrease MCP-1 levels.
出处 《中国临床医学》 2010年第2期216-219,共4页 Chinese Journal of Clinical Medicine
关键词 单核细胞趋化蛋白-1 2型糖尿病 葡萄糖钳夹技术 胰岛素抵抗 Monocyte chemoattractant protein-1 Type 2 diabetes mellitus Glucose clamp technique Iusulin resistance
  • 相关文献

参考文献9

  • 1Wada T,Furuichi K,Sakai N,et al.Up-regulation of monocyte chemoattractant protein l in tubulointerstitial 1esions of human diabetic nephropathy[J].Kidney Int,2000,58:1492-1499.
  • 2Rollins BJ.Chemokines[J].Blood,1997,90(3):909-928.
  • 3DeFronzo RA,Tobin JD,Andres R.Glucose clamp technique:a method for quantifying insulin secretion and resistance[J].AM J Physiol,1979,237(3):214-223.
  • 4Rizza RA,Mandrino IJ,Gerich JE.Dose-response characteristics for effects of insulin on production and utilization of glucose in man[J].Am J Physiol,1981,240:630-639.
  • 5DeFronzo RA,Hendler R,Simonson D.Insulin resistance in a prominent feature of insulin-dependent diabetes[J].Diabetes,1928,31:795-800.
  • 6Takahashi K,Mizuarai S,Araki H,et al.Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice[J].J Biol Chem,2003,278(47):46654-46660.
  • 7Sartipy P,Loskutoff DJ.Monocyte chemoattractant protein 1 in obesity and insulin resistance[J].Proc Natl Acad Sci U S A,2003,100(12):7265-7270.
  • 8Lee SK,Kim BS,Yang WS,et al.High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells[J].Kidney Int,2001,60(1):55-64.
  • 9Chiarelli F,Cipollone F,Mohn A,et al.Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes[J].Diabetes Care,2002,25(10):1829-1834.

同被引文献23

  • 1祁燕,谢自敬,阿不力克木.乌鲁木齐市维吾尔族成年人代谢综合征流行病学调查[J].中国现代医学杂志,2004,14(19):155-156. 被引量:46
  • 2王从杰,孙静,张志珺.抗精神病药与2型糖尿病[J].临床精神医学杂志,2004,14(5):313-314. 被引量:18
  • 3李东锋,杨波,杨汉东,汤天军,闵新文,李毅,张宾.代谢综合征患者血清抵抗素与血脂、肥胖和胰岛素抵抗关系的研究[J].中国临床医学,2005,12(2):206-208. 被引量:12
  • 4Saad MF,Lillioja S,Nyomba BL,et al.Racial differences in the relationship between blood pressure and insulin resistance[J].N Engl J Med,1991,324(11):733-739.
  • 5Yong-Woo P,Shankuan Z,Latha P,et al.The Metabolic syndrome:prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey,1988-1994[J].Arch Intern Med,2003,163(4):427-436.
  • 6Moller DE,Kaufman KD.Metabolic syndrome:A clinical and molecular perspective[J].Annu Rev Med,2005,56(1):45-62.
  • 7Mueneh J, Hamer AM. Adverse effects of antipsychotic medi- cations[J]. Am Faro Physician, 2010,81 (5) : 617 - 622.
  • 8Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistanee[J]. Proe National Acad Sci U S A,2003,100(12) :7 265-7 270.
  • 9Cope MB, Nagy TR, Fernandez JR, et al. Antipsychotic drug -induced weight gain: development of an animal model[J].Int J Obes(Lond),2005,29(6):607-614.
  • 10高燕燕.不同药物对高脂饮食诱导肥胖大鼠Ghrelin、TNF-a、Adiponectin、MCP-1的影响[M].济南:山东大学,2006.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部